A new study and several lawsuits link Xarelto with uncontrollable bleeding injuries and increased risks of hemorrhage, stroke, pulmonary embolism, and death. Attorneys for Levinson Axelrod are investigating claims that the drug may be too dangerous for patients.
Edison, NJ (PRWEB) August 07, 2014
The law firm of Levinson Axelrod is examining new reports that the blood thinner Xarelto, manufactured in Germany by Janssen Pharmaceuticals, Inc., and Bayer AG, may be linked to severe adverse side effects, such as uncontrollable bleeding and an increased risk of blood clots.
Reuters reported on June 14, 2014, that several lawsuits had been filed in the United States against the makers of Xarelto, German pharmaceutical manufacturers Janssen Pharmaceuticals, Inc., and Bayer AG.
One of these lawsuits, Packard v. Janssen Research & Development, LLC, et al. (Case No. 9:14cv 80831, U.S. District Court for the Southern District of Florida) accuses the pharmaceutical companies of failing to warn consumers of the potential side effects of the medication and intentionally misleading patients about Xarelto's safety.
A May 7, 2014 report by the Institute for Safe Medication Practices (ISMP) charted the negative side effects of Xarelto conveyed to the FDA in 2013. The report found that Xarelto side effects are increasing steadily as the drug becomes more popular.
According to the ISMP, there were 989,000 prescriptions written for Xarelto in 2013. In the first three months of that year, there were 680 side effects reported, which included hemorrhages, strokes, pulmonary embolisms, and deaths. While uncontrolled bleeding complications were most common (due to the nature of anticoagulants), the same report also noted that lower, 10mg doses of Xarelto were linked to an increased risk of blood clots.
Attorneys at Levinson Axelrod are taking note of the growing number of complaints against Xarelto, and are investigating potential lawsuits on behalf of those who were injured by the drug. Levinson Axelrod is pleased to offer free consultations for anyone who took Xarelto and may have suffered adverse effects from the medication.